Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.

BACKGROUND: Lamivudine (3TC) is a potent inhibitor of both Hepatitis B virus (HBV) and Human Immunodeficiency Virus (HIV) replication and is part of first-line highly active antiretroviral therapy (HAART) in the Gambia. Unfortunately, the effectiveness of 3TC against HBV is limited by the emergence...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Stewart, B, Jobarteh, M, Sarge-Njie, R, Alabi, A, de Silva, T, Peterson, K, Peterson, I, Whittle, H, Rowland-Jones, S, Jaye, A, Cotten, M, Mendy, M
Format:	Journal article
Sprache:	English
Veröffentlicht:	BioMed Central 2011
Schlagworte:	Viruses Pharmacology Infectious diseases Africa

Ähnliche Einträge

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
von: Stewart Balint, et al.
Veröffentlicht: (2011-12-01)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
von: Jobarteh, M, et al.
Veröffentlicht: (2010)

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.
von: Jallow, S, et al.
Veröffentlicht: (2009)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
von: Lijun Gu, et al.
Veröffentlicht: (2015-01-01)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians
von: Hall Andrew, et al.
Veröffentlicht: (2010-09-01)

Lamivudine treatment for severe acute HBV hepatitis
von: Andrea Lisotti, Francesco Azzaroli, Federica Buonfiglioli, Marco Montagnani, Flavio Alessandrelli, Giuseppe Mazzella
Veröffentlicht: (2008-01-01)

Validation of hepatitis B surface antigen (HBsAg) rapid test to screen HBV infection in rural Gambia
von: H.F. Njai, et al.
Veröffentlicht: (2014-04-01)

Novel oligonucleotide assay detects HBV pre-core and basal core mutations in HBV-infected Gambians
von: Mendy, M, et al.
Veröffentlicht: (2006)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
von: Crozier Sarah, et al.
Veröffentlicht: (2008-04-01)

Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.
von: Ondondo, B, et al.
Veröffentlicht: (2008)

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
von: Aoran Luo, et al.
Veröffentlicht: (2018-09-01)

Safety, immunogenicity, and efficacy results of a phase II trial of therapeutic vaccines for chronic HBV in the Gambia.
von: McConkey, S, et al.
Veröffentlicht: (2004)

Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa
von: Okomo Uduak, et al.
Veröffentlicht: (2012-10-01)

Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver
von: Daniel Traum, et al.
Veröffentlicht: (2021-04-01)

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana
von: Bonolo B. Phinius, et al.
Veröffentlicht: (2024-04-01)

Structural and biophysical studies of HIV Rev and HBV e-antigen
von: DiMattia, M
Veröffentlicht: (2012)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
von: Costantini Andrea, et al.
Veröffentlicht: (2011-11-01)

Treatment of chronic HBV infection in developing countries
von: Rosa Zampino, et al.
Veröffentlicht: (2016-11-01)

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.
von: Jallow, S, et al.
Veröffentlicht: (2006)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
von: Yindom, L, et al.
Veröffentlicht: (2017)

Seroprevalence of HBV among Egyptian municipal solid waste workers
von: Ekram W. Abd El-Wahab, et al.
Veröffentlicht: (2019-06-01)

Chronicles of HBV and the Road to HBV Cure
von: Rukaiya Bashir Hamidu, et al.
Veröffentlicht: (2023-04-01)

Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history
von: Yuan O. Zhu, et al.
Veröffentlicht: (2017-10-01)

Neurologic Manifestations of Human Immunodeficiency Virus-2: Dementia, Myelopathy, and Neuropathy in West Africa
von: Choi, Y, et al.
Veröffentlicht: (2010)

Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan
von: M. M. Badawi, et al.
Veröffentlicht: (2018-09-01)

Etiology of Kidney Diseases With Proteinuria in the Gambia/West Africa
von: Udo Vester, et al.
Veröffentlicht: (2022-03-01)

HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.
von: van Tienen, C, et al.
Veröffentlicht: (2010)

Virological profiles of hepatitis B virus (HBV)-infected African patients treated with tenofovir
von: H.F. Njai, et al.
Veröffentlicht: (2014-04-01)

Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms
von: Kester, Jemila C., et al.
Veröffentlicht: (2020)

HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme
von: Amina Sow, et al.
Veröffentlicht: (2022-10-01)

The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
von: Qingqing Cai, et al.
Veröffentlicht: (2016-01-01)

Is HBV RNA a new endpoint of HBV cure?
von: Henry Lik Yuen Chan
Veröffentlicht: (2024-09-01)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
von: Lu Hongzhu, et al.
Veröffentlicht: (2012-03-01)

Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.
von: Zaidi, I, et al.
Veröffentlicht: (2012)

Development and validation of HBV surveillance models using big data and machine learning
von: Weinan Dong, et al.
Veröffentlicht: (2024-12-01)

Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China
von: Su M, et al.
Veröffentlicht: (2018-10-01)

Epidemiology of HBV in Pregnant Women, South West Nigeria
von: Glory Atilola, et al.
Veröffentlicht: (2018-12-01)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
von: Francisco Campello do Amaral Mello, et al.
Veröffentlicht: (2012-05-01)

Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
von: Arabe Juçara, et al.
Veröffentlicht: (2004-08-01)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
von: Louis-Marie Yindom, et al.
Veröffentlicht: (2017-01-01)